Ideas to Action:

Independent research for global prosperity

Global Health Policy

CGD experts discuss such issues as health financing, drug resistance, clinical trials, vaccine development, HIV/AIDS, and health-related foreign assistance.

X

Global Health Policy

Feed

 

BMGF’s New President for Global Development: A Bonanza for Global Health?

Chris Elias, President & CEO at PATH, will step down from his current position and join the Bill & Melinda Gates Foundation (BMGF) as President for global DEVELOPMENT in February 2012. Yes, that’s global development, not global health. First reactions from many in global health lamented the "loss" of one of the field’s most accomplished and visible experts. But as we digested the details of the announcement and discussed its implications, we realized that the Foundation’s decision could be a bonanza for global health. Here are two reasons why:

Will the Health Systems Funding Platform Coordinate or Complicate?

The latest effort to address aid coordination problems and health system issues – the Health System Funding Platform (the Platform) – is evolving slowly and beginning to recreate the same traps it was supposed to solve. In a paper released this month, Bill Savedoff and I show how the natural tendency for aid agencies to fall back on measuring and paying for inputs is likely to undermine the Platform’s goals. Linking funding to results is the most promising way for the donors to achieve the aims they initially set for the initiative.

Break Out the Champagne! The AMC Delivers Vaccines

This weekend, children in Nicaragua received Advance Market Commitment (AMC)-financed pneumococcal vaccines that protect against the strains of pneumonia, meningitis and sepsis common in poor countries. Thanks in part to the AMC, the new and improved pneumo vaccines will reach the world's poorest children during the same year children in wealthy countries obtained access, and at a fraction of the price.

Women Deliver 2010: A Second Chance for the World to Deliver for Women

The much-anticipated Women Deliver 2010 conference opened with a rousing call for global action for women’s health. A star-studded line-up of health and development leaders committed themselves and urged others to do more to reduce child and maternal deaths. The rhetoric and passion sounds a lot like the calls we heard fifteen years ago that went unheeded. Today there is a second chance for the world to deliver for women. Will this time be different?

Making Sense of New Maternal Mortality Numbers: Four Take-Aways for Policy and Research Action

This is a joint post with Katherine Douglas.

A new Lancet paper by a team of researchers at the University of Washington’s Institute for Health Metrics and Evaluation has caused quite a stir about the progress we are making towards Millennium Development Goal (MDG) 5: To reduce maternal mortality ratios by three quarters from 1990 to 2015! I have long wondered why no one was making an effort to question the ostensibly stagnant “500,000 maternal deaths per year” estimate, so this team’s effort to provide us with the new numbers (and reinvigorated focus!) is very welcome. With a few exceptions (Karen Grepin’s excellent blog being one), I have yet to see much of a response from the global health community, although there has been quite a lively discussion in the development community at large (see Bill Easterly’s blog for example) about differences in modeling outcomes, whether these new maternal mortality numbers are better than the older ones and whether these new figures indicate the efficacy of safe motherhood programs, among other topics. However, two important issues are missing from these conversations: The extreme limitations of existing maternal mortality data, and what we can take away from these new estimates.

The End of Exile for Sexual and Reproductive Health and Rights

When it comes to Secretary of State Hillary Clinton, no sliver of the international development community is more enamored than the sexual and reproductive health and rights (SRHR) crowd (yes, that’s their self-designation). Last Friday, Hillary returned the love. In a speech (see the full text here) in the regal Benjamin Franklin reception room at the State Department, Secretary of State Clinton and many of her top staff brought the international dimension of reproductive health and family planning in from the cold. It’s been a long winter.

Dispute over Pneumococcal Vaccine Initiative: A Response

An article by Ann Danaiya Usher in the December 5 edition of the Lancet focuses on aspects of the Advance Market Commitment pilot for pneumococcal vaccine that appear to be causing confusion. The article is similar to one published by the author in Development Today, a publication that has issued a series of negative (or at least skeptical) pieces about the AMC over the past few years.

Pages

Tags